Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1999-02-16
1999-08-31
Spivack, Phyllis G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
A61K 350
Patent
active
059454199
ABSTRACT:
A method for treating allergic rhinitis by administrating to a subject in need thereof an effective amount of a compound of the formula: ##STR1## wherein R.sup.2 and R.sup.3 independently represent a hydrogen atom or a C.sub.1-4 alkyl group, and R.sup.4a and R.sup.5a independently represent a hydrogen atom or a C.sub.1-4 alkyl group, or a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 5011835 (1991-04-01), Peet et al.
patent: 5039689 (1991-08-01), Daluge
Berkow et al.,"The Merck Manual" Merck Research Laboratories, USA 16th edition, chapter 98, pp. 1230-1231 (1992).
Labrakis-Lazanas, Katerina et al., "PAF of Biological Fluids in Disease: Blood Levels in Allergic Rhinitis" vol. 73, pp. 379-382; Haematologica (1998).
Chemical Abstract AN 93-153853, Korth, to EP 540766, (11-91).
Chemical Abstracts, AN 1990:629449 Misawa et al., (1-90).
Chemical Abstracts, AN 1990:214771 Fukuda et al., (1-90).
Ashida Yasuko
Matsumoto Tatsumi
Miyake Akio
Spivack Phyllis G.
Takeda Chemical Industries Ltd.
LandOfFree
Method for treating allergic rhinitis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating allergic rhinitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating allergic rhinitis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2426571